Preview

Rational Pharmacotherapy in Cardiology

Advanced search

RATIONAL PHARMACOTHERAPY IN TAKOTSUBO CARDIOMYOPATHY

https://doi.org/10.20996/1819-6446-2012-8-6-777-780

Full Text:

Abstract

Rational pharmacotherapy in Takotsubo cardiomyopathy is based on clinical picture and data of functional and laboratory investigations of concrete patient. In patients with hypotension and moderate-to-severe left ventricle outflow tract obstruction inotropic agents must not to be used because they can worsen the degree of obstruction. In these patients beta blockers can improve hemodynamics by causing resolution of the obstruction. If intraventricular thrombus is detected, anticoagulation for at least 3 months is recommended. The duration of anticoagulant therapy may be modified depending on the extent of cardiac function recovery and thrombus resolution. For patients without thrombus but with severe left ventricular dysfunction, anticoagulation is recommended until the akinesis or dyskinesis has resolved but not more than 3 months.

About the Authors

S. Marchev
Bulgarian Cardiac Institute
Bulgaria


T. Vekov
Bulgarian Cardiac Institute
Bulgaria


References

1. Sato H, Tateishi H, Uchida T, et al. Takotsubo type cardiomyopathy due to multivessel spasm. In: Haze K, Hon M Kodama K., eds. Clinical Aspect of Myocardial Injury: From Ischaemia to Heart Failure. Tokyo: Kagakuhyouronsya; 1990: 56–64.

2. Sharkey SW, Lesser JR and Maron BJ. Takotsubo (Stress) Cardiomyopathy. Circulation 2011; 124:e460–e462.

3. Marchev S. Clinical cases: Takotsubo in Bulgaria. ESC echocardiography course: Advanced Clinical Echocardiography with Live Demonstrations. Sofia, 2006.

4. Marchev S. Takotsubo in Bulgaria. The Eleventh Annual Meeting of the European Association of Echocardiography (EUROECHO 2007). Lisbon, Portugal, December 5–8, 2007.

5. Tomich EB. Takotsubo Cardiomyopathy. Available on: http://emedicine.medscape.com/article/1513631. Cited: August 03, 2012.

6. Yamashita K, Ishii H, Hirota K et al. Takotsubo cardiomyopathy during ambulatory anesthesia for bladder hydrodistension therapy. A case report. Korean J Anesthesiol 2012; 62(5): 484–7.

7. Kyriacou C. Identifying Takotsubo Cardiomyopathy. Available on: http://www.escardio.org/communities/councils/ccp/e-journal/volume10/Pages/Takotsubo-Cardiomyopathy-identification-treatment.aspx. Cited: August 03, 2012.

8. Reeder GS, Prasad A. Stress-induced (takotsubo) cardiomyopathy. Available on: http://www.upto-date.com/contents/stress-induced-takotsubo-cardiomyopathy. Cited: August 03, 2012.

9. Paur H, Wright P,Sikkel MB, et al. High Levels of Circulating Epinephrine Trigger Apical Cardiodepression in a 2-Adrenoceptor/Gi-Dependent Manner: A New Model of Takotsubo Cardiomyopathy. Circulation 2012;126(6):697–706.


For citation:


Marchev S., Vekov T. RATIONAL PHARMACOTHERAPY IN TAKOTSUBO CARDIOMYOPATHY. Rational Pharmacotherapy in Cardiology. 2012;8(6):777-780. (In Russ.) https://doi.org/10.20996/1819-6446-2012-8-6-777-780

Views: 334


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)